FOLD

Amicus Therapeutics, Inc.

Healthcare · USD

Set alert

Price alert · FOLD

All alert types
14.49 USD 0.00 0.00%
As of Apr 27, 2026 Extended hours 14.49 0.00%
Bid
14.49 × 22
Ask
14.50 × 29
14.49 Day range 14.49
8.62 52-week range 14.50
YTD
+1.76%
1 year
+97.14%
Open
14.49
Prev close
14.49
Mkt cap
4.55B
Vol
0
Avg vol
2.62M
EPS
-0.08
P/E
-783.24
Div yield
0.00%
More statistics
Low
14.49
High
14.49
Beta
0.48
Inst. own
104.39%
Dividend
0.00
Earnings
May 7, 2026

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for FOLD has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

1.34 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -162×
FY 2016: -3.3×FY 2017: -7.8×FY 2018: -5.1×FY 2019: -6.6×FY 2020: -21.6×FY 2021: -12.6×FY 2022: -14.9×FY 2023: -27.8×FY 2024: -52.3×FY 2025: -162×
FY 2016 5y median -27.8× FY 2025
P/S 6.9×
FY 2016: 135×FY 2017: 59.8×FY 2018: 19.5×FY 2019: 12.8×FY 2020: 22.9×FY 2021: 10.3×FY 2022: 10.7×FY 2023: 10.5×FY 2024: 5.4×FY 2025: 6.9×
FY 2016 5y median 10.3× FY 2025
P/B 16.0×
FY 2016: 1.9×FY 2017: 6.3×FY 2018: 5.2×FY 2019: 4.9×FY 2020: 20.9×FY 2021: 10.2×FY 2022: 28.7×FY 2023: 26.1×FY 2024: 14.8×FY 2025: 16.0×
FY 2016 5y median 16.0× FY 2025
P/FCF 147×
FY 2016: -4.3×FY 2017: -10.0×FY 2018: -5.8×FY 2019: -8.7×FY 2020: -25.3×FY 2021: -15.2×FY 2022: -20.7×FY 2023: -54.7×FY 2024: -76.6×FY 2025: 147×
FY 2016 5y median -20.7× FY 2025
EV/EBITDA 86.6×
FY 2016: -3.3×FY 2017: -5.4×FY 2018: -6.3×FY 2019: -7.3×FY 2020: -25.7×FY 2021: -16.4×FY 2022: -19.2×FY 2023: -47.6×FY 2024: 105×FY 2025: 86.6×
FY 2016 5y median -16.4× FY 2025
EV/Sales 7.3×
FY 2016: 128×FY 2017: 62.9×FY 2018: 22.2×FY 2019: 13.2×FY 2020: 24.0×FY 2021: 10.9×FY 2022: 11.6×FY 2023: 11.0×FY 2024: 5.9×FY 2025: 7.3×
FY 2016 5y median 10.9× FY 2025
FCF Yield 0.7%
FY 2016: -23.4%FY 2017: -10.0%FY 2018: -17.2%FY 2019: -11.5%FY 2020: -4.0%FY 2021: -6.6%FY 2022: -4.8%FY 2023: -1.8%FY 2024: -1.3%FY 2025: 0.7%
FY 2016 5y median -1.8% FY 2025

Profitability

Gross Margin 87.3%
FY 2016: 83.2%FY 2017: 83.1%FY 2018: 84.2%FY 2019: 87.9%FY 2020: 88.1%FY 2021: 88.7%FY 2022: 88.3%FY 2023: 90.7%FY 2024: 90.0%FY 2025: 87.3%
FY 2016 5y median 88.7% FY 2025
Operating Margin 5.4%
FY 2016: -3668.6%FY 2017: -1196.8%FY 2018: -360.3%FY 2019: -166.8%FY 2020: -94.7%FY 2021: -67.6%FY 2022: -64.4%FY 2023: -19.3%FY 2024: 4.7%FY 2025: 5.4%
FY 2016 5y median -19.3% FY 2025
Net Margin -4.3%
FY 2016: -4034.7%FY 2017: -769.0%FY 2018: -382.5%FY 2019: -195.6%FY 2020: -106.1%FY 2021: -82.0%FY 2022: -71.9%FY 2023: -38.0%FY 2024: -10.6%FY 2025: -4.3%
FY 2016 5y median -38.0% FY 2025
ROE -9.9%
FY 2016: -55.5%FY 2017: -80.5%FY 2018: -101.8%FY 2019: -74.8%FY 2020: -96.7%FY 2021: -81.5%FY 2022: -192.3%FY 2023: -94.6%FY 2024: -28.9%FY 2025: -9.9%
FY 2016 5y median -81.5% FY 2025
ROIC -679.2%
FY 2016: -19.3%FY 2017: -50.2%FY 2018: -46.7%FY 2019: -41.7%FY 2020: -32.3%FY 2021: -26.9%FY 2022: -34.9%FY 2023: -12.5%FY 2024: 3.9%FY 2025: -679.2%
FY 2016 5y median -26.9% FY 2025
ROA -2.9%
FY 2016: -19.3%FY 2017: -45.3%FY 2018: -44.2%FY 2019: -41.9%FY 2020: -31.2%FY 2021: -27.7%FY 2022: -32.7%FY 2023: -19.5%FY 2024: -7.1%FY 2025: -2.9%
FY 2016 5y median -19.5% FY 2025

Growth (YoY)

Revenue 20.0%
FY 2016: 0.0%FY 2017: 644.9%FY 2018: 147.1%FY 2019: 99.7%FY 2020: 43.2%FY 2021: 17.1%FY 2022: 7.8%FY 2023: 21.3%FY 2024: 32.3%FY 2025: 20.0%
FY 2016 FY 2025
Operating Income 38.7%
FY 2016: -39.4%FY 2017: -143.0%FY 2018: 25.6%FY 2019: 7.5%FY 2020: 18.8%FY 2021: 16.4%FY 2022: -2.8%FY 2023: 63.6%FY 2024: 132.2%FY 2025: 38.7%
FY 2016 FY 2025
EPS (diluted) 51.2%
FY 2016: -24.2%FY 2017: -24.2%FY 2018: -1.6%FY 2019: 21.3%FY 2020: 27.7%FY 2021: 14.0%FY 2022: 10.9%FY 2023: 37.8%FY 2024: 64.7%FY 2025: 51.2%
FY 2016 FY 2025
Free Cash Flow 179.7%
FY 2016: -49.1%FY 2017: -40.6%FY 2018: -39.2%FY 2019: 11.7%FY 2020: 12.5%FY 2021: 12.7%FY 2022: 17.5%FY 2023: 55.1%FY 2024: 51.1%FY 2025: 179.7%
FY 2016 FY 2025

Financial Health

Current Ratio 2.8×
FY 2016: 3.1×FY 2017: 5.6×FY 2018: 6.4×FY 2019: 4.0×FY 2020: 4.5×FY 2021: 4.1×FY 2022: 3.0×FY 2023: 2.9×FY 2024: 3.4×FY 2025: 2.8×
FY 2016 5y median 3.0× FY 2025
Quick Ratio 1.9×
FY 2016: 3.0×FY 2017: 5.5×FY 2018: 6.3×FY 2019: 3.9×FY 2020: 4.3×FY 2021: 3.9×FY 2022: 2.9×FY 2023: 2.5×FY 2024: 2.6×FY 2025: 1.9×
FY 2016 5y median 2.6× FY 2025
Debt / Equity 1.8×
FY 2016: 0.4×FY 2017: 0.5×FY 2018: 0.9×FY 2019: 0.4×FY 2020: 1.5×FY 2021: 1.4×FY 2022: 3.7×FY 2023: 2.8×FY 2024: 2.3×FY 2025: 1.8×
FY 2016 5y median 2.3× FY 2025
Net Debt / EBITDA 5.0×
FY 2016: 0.2×FY 2017: -0.3×FY 2018: -0.8×FY 2019: -0.2×FY 2020: -1.1×FY 2021: -1.0×FY 2022: -1.5×FY 2023: -2.2×FY 2024: 7.8×FY 2025: 5.0×
FY 2016 5y median -1.0× FY 2025
Interest Coverage 0.7×
FY 2016: -33.7×FY 2017: -25.6×FY 2018: -14.7×FY 2019: -16.1×FY 2020: -11.0×FY 2021: -6.4×FY 2022: -5.7×FY 2023: -1.5×FY 2024: 0.5×FY 2025: 0.7×
FY 2016 5y median -1.5× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31